
Hospital Formulary Strategy & Committee Preparation
Map hospital decision-makers and win formulary approval with evidence-based committee strategies
What You Can Do
You can rapidly map the clinical, pharmacy, and procurement decision-makers at target hospital systems, assemble persuasive health economic and clinical evidence tailored to each stakeholder's priorities, and develop presentation strategies that address objections before committee meetings occur. This skill compresses typical 6+ month formulary cycles into 2-3 meeting cycles by organizing evidence strategically and anticipating pharmacoeconomic scrutiny.
Features
identify P&T committee members, clinical champions, pharmacy directors, and procurement decision-makers by role and evidence priority
organize peer-reviewed studies, health economic data, and real-world outcomes into argument frameworks that withstand committee scrutiny
benchmark competitive positioning and identify gaps in your clinical dossier vs. hospital priorities
develop section-by-section outlines (clinical efficacy, safety, health economics, budget impact) tailored to committee composition
surface stakeholder-specific concerns and pre-build responses before formal presentations
calculate justifiable pricing, exclusivity terms, and volume protections based on clinical value and hospital budget impact
pinpoint missing data or studies needed to overcome specific formulary barriers
Example Output
Stakeholder Map Output:
- P&T Committee Chair (pharmacist): Prioritizes safety data, drug interactions, clinical outcome comparisons
- Chief Medical Officer: Focused on clinical efficacy vs. standard of care and patient outcomes
- Procurement Director: Evaluates budget impact, cost per unit, volume commitments
- Nursing Leadership: Concerned with ease of use, workflow integration, training requirements
Evidence Synthesis:
- Head-to-head efficacy comparison: Your product shows 23% superior response rate in diabetic patients (cite Study XYZ, N=850)
- Budget impact model: Hospital saves $127K annually in reduced complications vs. current standard (hospital-specific calculation)
- Safety profile summary: Adverse event rate 8% lower than competitor (confidence interval 95%)
Committee Presentation Outline: Slide 1-3: Clinical need and competitive landscape | Slide 4-6: Efficacy/safety evidence comparison | Slide 7-8: Budget impact and ROI | Slide 9-10: Implementation timeline and support
What's Included
- SKILL.md instruction file with formulary strategy frameworks and compliance guardrails:
- Stakeholder Mapping Template: identify and profile decision-makers by hospital system
- Clinical Evidence Synthesis Checklist: organize studies by evidence type and stakeholder relevance
- P&T Committee Presentation Outline: modular slides covering clinical, economic, and operational priorities
- Objection Response Framework: pre-built answers to common pharmacy, clinical, and procurement barriers
- Budget Impact Calculator: template for hospital-specific cost-benefit analysis
Who It's For
- Pharma sales representatives — hospital/health system account management and formulary strategy
- Medical science liaisons — clinical evidence synthesis and stakeholder engagement
- Market access specialists — health economics, competitive positioning, formulary planning
- Hospital relations managers — institutional account strategy and committee preparation
- Product managers (pharma) — formulary adoption forecasting and launch planning
Best For
- Preparing for P&T (Pharmacy & Therapeutics) committee presentations to hospital systems
- Mapping hospital stakeholders and their decision criteria before initial outreach
- Synthesizing clinical and health economic evidence into committee-ready presentations
- Identifying formulary barriers and building objection responses before committee meetings
- Calculating budget impact models and negotiating volume commitments with hospital procurement







